The lawsuit against Elanco for alleged misrepresentation of Zenrelia's safety profile is a significant legal issue. Such lawsuits can lead to financial penalties, reputational damage, and increased scrutiny, all of which can negatively impact the stock price. The encouragement for investors with losses to contact Hagens Berman suggests that the issue has already affected investors, indicating a potential for further negative impact.